IRIS Accounts Production v24.2.0.383 08480585 director 1.4.23 31.3.24 31.3.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh084805852023-03-31084805852024-03-31084805852023-04-012024-03-31084805852022-03-31084805852022-04-012023-03-31084805852023-03-3108480585ns15:EnglandWales2023-04-012024-03-3108480585ns14:PoundSterling2023-04-012024-03-3108480585ns10:Director12023-04-012024-03-3108480585ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108480585ns10:SmallEntities2023-04-012024-03-3108480585ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108480585ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3108480585ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108480585ns10:FullAccounts2023-04-012024-03-310848058512023-04-012024-03-3108480585ns10:OrdinaryShareClass12023-04-012024-03-3108480585ns5:CurrentFinancialInstruments2024-03-3108480585ns5:CurrentFinancialInstruments2023-03-3108480585ns5:ShareCapital2024-03-3108480585ns5:ShareCapital2023-03-3108480585ns5:RetainedEarningsAccumulatedLosses2024-03-3108480585ns5:RetainedEarningsAccumulatedLosses2023-03-3108480585ns5:NetGoodwill2023-04-012024-03-3108480585ns5:LeaseholdImprovements2023-04-012024-03-3108480585ns5:PlantMachinery2023-04-012024-03-3108480585ns5:FurnitureFittings2023-04-012024-03-3108480585ns5:ComputerEquipment2023-04-012024-03-3108480585ns5:NetGoodwill2023-03-3108480585ns5:NetGoodwill2024-03-3108480585ns5:NetGoodwill2023-03-3108480585ns5:LeaseholdImprovements2023-03-3108480585ns5:PlantMachinery2023-03-3108480585ns5:FurnitureFittings2023-03-3108480585ns5:ComputerEquipment2023-03-3108480585ns5:LeaseholdImprovements2024-03-3108480585ns5:PlantMachinery2024-03-3108480585ns5:FurnitureFittings2024-03-3108480585ns5:ComputerEquipment2024-03-3108480585ns5:LeaseholdImprovements2023-03-3108480585ns5:PlantMachinery2023-03-3108480585ns5:FurnitureFittings2023-03-3108480585ns5:ComputerEquipment2023-03-3108480585ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3108480585ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3108480585ns5:DeferredTaxation2023-03-3108480585ns5:DeferredTaxation2023-04-012024-03-3108480585ns5:DeferredTaxation2024-03-3108480585ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 08480585 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

KINETIC HEALTHCARE LTD

KINETIC HEALTHCARE LTD (REGISTERED NUMBER: 08480585)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Balance sheet 1

Notes to the financial statements 2


KINETIC HEALTHCARE LTD (REGISTERED NUMBER: 08480585)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
Fixed assets
Intangible assets 4 - -
Tangible assets 5 12,438 11,814
12,438 11,814

Current assets
Stocks 1,500 1,500
Debtors 6 2,335 577
Cash at bank and in hand 86,798 76,560
90,633 78,637
Creditors
Amounts falling due within one year 7 19,502 12,706
Net current assets 71,131 65,931
Total assets less current liabilities 83,569 77,745

Provisions for liabilities 8 2,612 2,245
Net assets 80,957 75,500

Capital and reserves
Called up share capital 9 100 100
Retained earnings 80,857 75,400
Shareholders' funds 80,957 75,500

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of comprehensive income has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 September 2024 and were signed by:




Dr M C Spruce - Director


KINETIC HEALTHCARE LTD (REGISTERED NUMBER: 08480585)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. Statutory information

Kinetic Healthcare Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 08480585. The registered office is 7 & 8 Church Street, Wimborne, Dorset, BH21 1JH and business address is 39 Preetz Way, Blandford Forum, Dorset, DT11 7XH.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts receivable, in respect of services provided in the ordinary course of business. Turnover is recognised when the service has been provided to the customer.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of the business has been fully amortised.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Straight line over 7 years
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all purchase, costs of conversion and other costs incurred in bringing stock to its present location and condition. Cost is calculated using the first-in, first-out formula. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

KINETIC HEALTHCARE LTD (REGISTERED NUMBER: 08480585)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. Accounting policies - continued

Financial instruments
Basic financial instruments are initially recognised at transaction price and accounted for according to the substance of the contractual arrangement, as either financial assets, liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company, after deducting all liabilities.

At each balance sheet date, financial instruments are measured at amortised cost using the effective interest method. Any losses arising from impairment are recognised in the profit and loss account in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 4 (2023 - 4 ) .

4. Intangible fixed assets
Goodwill
£   
Cost
At 1 April 2023
and 31 March 2024 56,000
Amortisation
At 1 April 2023
and 31 March 2024 56,000
Net book value
At 31 March 2024 -
At 31 March 2023 -

5. Tangible fixed assets
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
Cost
At 1 April 2023 1,500 49,827 8,334 2,982 62,643
Additions - 140 6,300 406 6,846
Disposals - (33,425 ) - - (33,425 )
At 31 March 2024 1,500 16,542 14,634 3,388 36,064
Depreciation
At 1 April 2023 1,500 41,553 5,166 2,610 50,829
Charge for year - 1,633 2,367 340 4,340
Eliminated on disposal - (31,543 ) - - (31,543 )
At 31 March 2024 1,500 11,643 7,533 2,950 23,626
Net book value
At 31 March 2024 - 4,899 7,101 438 12,438
At 31 March 2023 - 8,274 3,168 372 11,814

KINETIC HEALTHCARE LTD (REGISTERED NUMBER: 08480585)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


6. Debtors: amounts falling due within one year
2024 2023
£    £   
Other debtors - 367
PAYE debtor 2,109 -
Prepayments 226 210
2,335 577

7. Creditors: amounts falling due within one year
2024 2023
£    £   
Trade creditors 172 -
Tax 14,440 6,578
Social security and other taxes - 1,034
Pension creditor 214 226
Directors' current accounts 122 477
Accruals and deferred income 4,554 4,391
19,502 12,706

8. Provisions for liabilities
2024 2023
£    £   
Deferred tax 2,612 2,245

Deferred
tax
£   
Balance at 1 April 2023 2,245
Charge to Income statement during year 367
Balance at 31 March 2024 2,612

9. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

10. Ultimate controlling party

The company is controlled by the director Dr M Spruce, who owns 100% of the issued share capital.